|
|
|
Volumn 26, Issue 3 SUPPL. 9, 1999, Pages 20-23
|
|
Emerging role of docetaxel (Taxotere) in the adjuvant therapy of breast cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTHRACYCLINE;
CYCLOPHOSPHAMIDE;
DOCETAXEL;
DOXORUBICIN;
EPIRUBICIN;
FLUOROURACIL;
METHOTREXATE;
PACLITAXEL;
ARTICLE;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
DRUG EFFECT;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
HUMAN;
METASTASIS;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
TREATMENT PLANNING;
ANTHRACYCLINES;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
CLINICAL TRIALS;
FEMALE;
HUMANS;
NEOPLASM METASTASIS;
PACLITAXEL;
TAXOIDS;
|
|
EID: 0032789395
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (4)
|
|
References (12)
|
